
Escitalopram Oxalate
CAS No. 219861-08-2
Escitalopram Oxalate ( Escitalopram Oxalate | Cipralex | Lexapro )
产品货号. M18247 CAS No. 219861-08-2
Escitalopram Oxalate 是一种选择性血清素 (5-HT) 再摄取抑制剂 (SSRI),Ki 为 0.89 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
25MG | ¥405 | 有现货 |
![]() ![]() |
50MG | ¥494 | 有现货 |
![]() ![]() |
100MG | ¥672 | 有现货 |
![]() ![]() |
200MG | ¥1029 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Escitalopram Oxalate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Escitalopram Oxalate 是一种选择性血清素 (5-HT) 再摄取抑制剂 (SSRI),Ki 为 0.89 nM。
-
产品描述Escitalopram Oxalate is a furancarbonitrile that is one of the selective serotonin uptake inhibitors used as an antidepressant. As a selective serotonin reuptake inhibitor (SSRI), escitalopram blocks the reuptake of serotonin by neurons in the central nervous system (CNS), thereby potentiating CNS serotonergic activity. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from tardive dyskinesia in preference to tricyclic antidepressants, which aggravate this condition.
-
体外实验——
-
体内实验Animal Model:Male Sprague-Dawley ratsDosage:10 mg/kg Administration:I.p.; daily for 28 days Result:Could selectively decrease phosphorylated tau accumulation in the hippocampus of stressed rats and could distinctly alleviate the hyperactivity of the HPA axis in both depressive and resistant rats.Animal Model:APP-PS1 hemizygous female mice (4 months of age)Dosage:2.5-5 mg/kg Administration:Daily; drinking water for a total of 4 months Result:At both doses significantly reduced plaque burden within the brains of these mice compared to littermate controls that drank only water. Hippocampal plaque load was significantly reduced by 28.7% and 34.4 % for ESC 2.5 mg/day and 5 mg/day, respectively.
-
同义词Escitalopram Oxalate | Cipralex | Lexapro
-
通路Chromatin/Epigenetic
-
靶点Epigenetic Reader Domain
-
受体SSRI
-
研究领域Neurological Disease
-
适应症——
化学信息
-
CAS Number219861-08-2
-
分子量414.43
-
分子式C22H23FN2O5
-
纯度>98% (HPLC)
-
溶解度H2O : ≥ 14.29 mg/mL; 34.48 mM
-
SMILESCN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.C(=O)(C(=O)O)O
-
化学全称(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;oxalic acid
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Mnie-Filali O, et al. Encephale, 2007, 33(6), 965-972.
产品手册




关联产品
-
PBRM1-BD2-IN-8
PBRM1-BD2-IN-8 (compound 34) 是一种强效的 PBRM1 Bromodomain 抑制剂 (PBRM1-BD2 Kd=4.4 μM, PBRM1-BD2 IC50=0.16 μM; PBRM1-BD5 Kd=25 μM),其具有抗癌活性。
-
PFI-1
PFI-1 是 BRD4 的选择性 BET(含溴结构域蛋白)抑制剂,在无细胞测定中 IC50 为 0.22 μM。
-
JWG-071
JWG-071 是首次报道的 ERK5 激酶选择性化学探针。JWG-071 提高了 ERK5 活性和 BRD4 选择性。JWG-071 将是反卷积 ERK5 和 BRD4 药理学急需的化学探针。